WallStreetZenWallStreetZen

NASDAQ: EGRX
Eagle Pharmaceuticals Inc Stock Ownership - Who owns Eagle Pharmaceuticals?

Insider buying vs selling

Have Eagle Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Scott Tarriff10% Owner2024-02-282,119$6.27
$13.29kSell
Brian Joseph CahillCHIEF FINANCIAL OFFICER2024-02-271,589$6.44
$10.23kSell
Scott Tarriff10% Owner2024-02-273,154$6.44
$20.31kSell
Brian Joseph CahillCHIEF FINANCIAL OFFICER2024-02-02934$5.85
$5.46kSell
Scott Tarriff10% Owner2024-01-054,322$5.13
$22.17kSell
Brian Joseph CahillChief Financial Officer2024-01-05735$5.13
$3.77kSell
Brian Joseph CahillChief Financial Officer2023-12-18452$4.76
$2.15kSell
Scott TarriffCEO2023-11-0210,694$13.87
$148.33kSell
Scott TarriffCEO2023-11-0110,925$13.82
$150.98kSell
Michael 1. GravesDirector2023-10-279,360$4.94
$46.24kBuy

1 of 2

EGRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EGRX insiders and whales buy or sell their stock.

EGRX Shareholders

What type of owners hold Eagle Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Proquest Investments Iv LP37.92%4,924,473$18.07MInsider
Jay Moorin37.36%4,852,479$17.81MInsider
Alain Schreiber37.36%4,852,479$17.81MInsider
Proquest Associates Iv LLC37.36%4,852,122$17.81MInsider
Proquest Management LLC37.12%4,821,269$17.69MInsider
Proquest Financial LLC36.85%4,785,770$17.56MInsider
Hudson Executive Capital LP11.88%1,543,242$5.66MInsider
Scott Tarriff11.19%1,453,244$5.33MInsider
Nantahala Capital Management LLC9.69%1,258,762$4.62MInstitution
Aigh Capital Management LLC9.14%1,186,509$4.35MInstitution

1 of 3

EGRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EGRX23.95%76.05%Net Selling
IXHL4.04%27.69%
BGXX5.61%66.54%Net BuyingNet Selling
DRRX8.83%91.17%
RMTI14.60%85.40%Net SellingNet Selling

Eagle Pharmaceuticals Stock Ownership FAQ

Who owns Eagle Pharmaceuticals?

Eagle Pharmaceuticals (NASDAQ: EGRX) is owned by 80.51% institutional shareholders, 255.66% Eagle Pharmaceuticals insiders, and 0.00% retail investors. Proquest Investments Iv LP is the largest individual Eagle Pharmaceuticals shareholder, owning 4.92M shares representing 37.92% of the company. Proquest Investments Iv LP's Eagle Pharmaceuticals shares are currently valued at $18.81M.

If you're new to stock investing, here's how to buy Eagle Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.